Adams Wealth Management

Position in LLY — ELI LILLY & Co

CIK 1803084 LOGAN, UT

Position in LLY

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$393,413

+$90,809 QoQ

Shares Held

328

-0.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

#3,946

of 4,605 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Adams Wealth Management holds $3,392,754 across 6 Drug Manufacturers - General names. LLY ranks #4 (11.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	6,766	$854,816
2	BMY	Bristol Myers Squibb Co	14,065	$810,425
3	ABBV	AbbVie Inc.	3,177	$799,460
4	LLY	ELI LILLY & Co This page	328	$393,413
5	PFE	Pfizer Inc	11,690	$281,495
6	MRK	Merck & Co., Inc.	1,970	$253,145

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$393,413	328	-0.3%	Shares	Other	2026-08-10
2026-03-31	$302,604	329	0.0%	Shares	Other	2026-05-12
2025-12-31	$353,569	329	-1.8%	Shares	Sole	2026-02-18
2025-09-30	$255,605	335	0.0%	Shares	Sole	2025-11-14
2025-06-30	$261,142	335	0.0%	Shares	Sole	2025-09-25
2025-03-31	$276,679	335	-4.3%	Shares	Sole	2025-05-13
2024-12-31	$270,200	350	-22.9%	Shares	Sole	2025-02-13
2024-09-30	$402,216	454	+11.0%	Shares	Sole	2024-10-28
2024-06-30	$370,300	409	+17.2%	Shares	Sole	2024-07-16
2024-03-31	$271,508	349	0.0%	Shares	Sole	2024-05-20
2023-12-31	$203,439	349	-4.6%	Shares	Sole	2024-02-12
2020-09-30	$54,175	366	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.